Clinical trial
Effectiveness and Safety of Electro-press Needle and Gamma-oryzanol for Menopause-associated Hot Flashes: Protocol of a Randomized Controlled Trial
NCT05922800 is registered in ClinicalTrials.gov with Dongzhimen Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Electro-press Needle and Gamma-oryzanol for Menopause-associated Hot Flashes: Protocol of a Randomized Controlled Trial
- Lead sponsor
- Dongzhimen Hospital, Beijing
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 19, 2023
- Completion date
- June 30, 2024
- Enrollment
- 64 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acupuncture therapy, hot flashes, perimenopausal disorder, postmenopausal symptoms